These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12694582)

  • 1. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes.
    Tait BD; Colman PG; Morahan G; Marchinovska L; Dore E; Gellert S; Honeyman MC; Stephen K; Loth A
    Tissue Antigens; 2003 Feb; 61(2):146-53. PubMed ID: 12694582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated Progression to Type 1 Diabetes in the Presence of
    Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
    Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies and human leucocyte antigen class II in first-degree family members of Mexican-American type 1 diabetic patients.
    Zeidler A; Raffel LJ; Costin G; Shaw SJ; Buchanan TA; Noble J; Rotter JI; Palmer J; Krischer JP; Wait C; Maclaren NK
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4957-62. PubMed ID: 11600569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity.
    Ilonen J; Kiviniemi M; Lempainen J; Simell O; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2016 Jul; 17 Suppl 22():8-16. PubMed ID: 27411431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic risk factors in autoimmune diabetes mellitus, their significance and function].
    Novota P; Cejková P; Cerná M; Andĕl M
    Cas Lek Cesk; 2004; 143(3):159-63. PubMed ID: 15134033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
    Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M
    Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age.
    Hathout EH; Hartwick N; Fagoaga OR; Colacino AR; Sharkey J; Racine M; Nelsen-Cannarella S; Mace JW
    Pediatrics; 2003 Apr; 111(4 Pt 1):860-3. PubMed ID: 12671124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterovirus Neutralizing Antibodies, Monocyte Toll Like Receptors Expression and Interleukin Profiles Are Similar Between Non-affected and Affected Siblings From Long-Term Discordant Type 1 Diabetes Multiplex-Sib Families: The Importance of HLA Background.
    Bergamin CS; Pérez-Hurtado E; Oliveira L; Gabbay M; Piveta V; Bittencourt C; Russo D; Carmona RC; Sato M; Dib SA
    Front Endocrinol (Lausanne); 2020; 11():555685. PubMed ID: 33071971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes.
    Rharbaoui F; Mayer A; Granier C; Bouanani M; Thivolet C; Pau B; Orgiazzi J; Madec AM
    Clin Exp Immunol; 1999 Jul; 117(1):30-7. PubMed ID: 10403912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus.
    Chuang LM; Wu HP; Chang CC; Tsai WY; Chang HM; Tai TY; Lin BJ
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):631-6. PubMed ID: 8977762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of the HLA-A*24:02, B*39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA-DR/DQ haplotypes in Finns.
    Mikk ML; Heikkinen T; El-Amir MI; Kiviniemi M; Laine AP; Härkönen T; Veijola R; Toppari J; Knip M; Ilonen J;
    HLA; 2017 Apr; 89(4):215-224. PubMed ID: 28185422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.
    Zhao LP; Alshiekh S; Zhao M; Carlsson A; Larsson HE; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Persson M; Samuelsson U; Örtqvist E; Pyo CW; Nelson WC; Geraghty DE; Lernmark Å;
    Diabetes; 2016 Mar; 65(3):710-8. PubMed ID: 26740600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.